Abstract: Paper towel rolls that exhibit novel combinations of physical properties, such as Basis Weight, Roll Density, and Roll Diameter, such that the paper towel rolls meet consumers' needs, and method for making such novel paper towel rolls and marketing such novel paper towel rolls are provided.

Abstract: Disclosed herein are methods, apparatus, and systems for iris recognition. A method includes acquiring at least two angularly differentiated iris images from a subject needing access, processing each of the at least two angularly differentiated iris images to generate at least one boundary delineated image from one of the at least two angularly differentiated iris images, applying image comparative analysis to the at least two angularly differentiated iris images to generate a boundary delineated image when the processing fails to produce the at least one boundary delineated image, segmenting and encoding one of the at least one boundary delineated image or the boundary delineated image to generate at least one iris template, matching the at least one iris template against an enrolled iris, and accepting the subject for access processing when the at least one iris template matches the enrolled iris.

Abstract: The present invention is directed to inhibitors of fibroblast growth factors, and more particularly to compounds of Formula (I), as well as compositions comprising Formula (I) and methods of using the compound of Formula (I) for the treatment or prevention of a disease, disorder, or medical condition mediated through the fibroblast growth factor receptor (FGFR), especially FGFR1-4. These diseases, disorders, or medical conditions include various cancers.

Abstract: Sanitary tissue product rolls that exhibit novel combinations of physical properties, such as Moment of Inertia, Roll Density, and Roll Diameter, such that the sanitary tissue product rolls meet consumers’ needs, and method for making such novel sanitary tissue product rolls and marketing such novel sanitary tissue product rolls are provided.

Abstract: An inventory monitoring system and process for monitoring inventory is shown and described herein. The system and process includes an RFID reader configured to collect or receive product code data, location data, and secondary metric data of inventory RFID tags relative to that of other RFID tags or markers for determining the location of the inventory from such data. From the information obtained from the RFID tags, the location of inventory in an environment can be determined.

Abstract: Sanitary tissue product rolls that exhibit novel combinations of physical properties, such as Moment of Inertia, Roll Density, and optionally Roll Diameter, such that the sanitary tissue product rolls meet consumers' needs, and method for making such novel sanitary tissue product rolls and marketing such novel sanitary tissue product rolls are provided.

Abstract: Sanitary tissue product rolls that exhibit novel combinations of physical properties, such as Moment of Inertia, Roll Density, and Roll Diameter, such that the sanitary tissue product rolls meet consumers' needs, and method for making such novel sanitary tissue product rolls and marketing such novel sanitary tissue product rolls are provided.

Abstract: The technology provides a computing device having a human presence sensor module. An image sensor of the human presence sensor module captures imagery, and the imagery is not disseminated outside of the human presence sensor module to another part of the computing device. One or more machine learning models, each trained to identify whether one or more persons are present in the imagery, are retrieved from memory within the human presence sensor module. The imagery received from the image sensor is processed using the one or more machine learning models to determine whether one or more persons are present in the imagery. Upon detection that one or more persons are present in the imagery, the human presence sensor module issues a signal to an operating system of the computing device so that the computing device can respond to that presence by performing one or more actions.

Abstract: Sanitary tissue product rolls that exhibit novel combinations of physical properties, such as Moment of Inertia, Roll Density, and optionally Roll Diameter, such that the sanitary tissue product rolls meet consumers' needs, and method for making such novel sanitary tissue product rolls and marketing such novel sanitary tissue product rolls are provided.

Abstract: The present invention is directed to inhibitors of Kirsten Rat sacoma virus (KRAS), and more particularly to compounds of Formula (I), as well as compositions comprising Formula I and methods of using the compound of Formula I for the treatment or prevention of a disease, disorder, or medical condition mediated through KRAS, especially the KRAS mutant G12C.

Abstract: Paper towel rolls that exhibit novel combinations of physical properties, such as Basis Weight, Roll Density, and Roll Diameter, such that the paper towel rolls meet consumers' needs, and method for making such novel paper towel rolls and marketing such novel paper towel rolls are provided.

Abstract: Methods of treating EGFR mutant-related cancers with a combination of an EGFR inhibitor of Formula (I) and the CDK4/6 inhibitor of Formula (II) and use of combinations of these compounds in the manufacture of medicaments for the treatment of EGFR mutant-related cancers are disclosed:

Abstract: Paper towel rolls that exhibit novel combinations of physical properties, such as Basis Weight, Roll Density, and Roll Diameter, such that the paper towel rolls meet consumers' needs, and method for making such novel paper towel rolls and marketing such novel paper towel rolls are provided.

Abstract: This application discloses novel substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, prodrugs, and compositions thereof, which are useful for the treatment or prevention of diseases or medical conditions mediated by epidermal growth factor receptors (EGFRs), including but not limited to a variety of cancers.

Abstract: A pharmaceutical formulation of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide (compound 1), in particular methanesulfonic acid salt thereof, and methods of using the pharmaceutical formulation for the treatment or prevention of diseases or medical conditions mediated through mutated forms of epidermal growth factor receptor (EGER), such as various cancers, are disclosed.

Abstract: The present disclosure provides [1,2,4]triazolo[4,3-b][1,2,4]triazine, [1,2,4] triazolo[4,3-b]pyridazine, and [1,2,3]triazolo[4,5-b]pyrazine derivatives, and pharmaceutically acceptable salts, solvates or prodrugs thereof, as tyrosine kinase c-MET inhibitors, which are useful as novel anticancer and/or anti-inflammatory agents.

Abstract: A pharmaceutical formulation of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide (compound 1), in particular methanesulfonic acid salt thereof, and methods of using the pharmaceutical formulation for the treatment or prevention of diseases or medical conditions mediated through mutated forms of epidermal growth factor receptor (EGFR), such as various cancers, are disclosed.

Abstract: An add-on device for attachment to a micropipette for determining the rotational movement and longitudinal displacement of a micropipette plunger for digitization, communication and quantification of pipetting actions.

Abstract: A method of treating dicot seedlings comprises contacting dicot seedlings with a composition comprising at least one cyclopropene one or more times prior to transplanting the dicot seedlings. A method of treating crop plants comprises contacting crop plants one or more times with a composition comprising at least one cyclopropene while the crop plants are at a specific development stage, such as reproductive stage.